What Researchers Did
Researchers presented a case report of a patient who developed scleral necrosis after pterygium surgery with mitomycin C and was subsequently treated with hyperbaric oxygen therapy.
What They Found
The patient's sclera revascularized and returned to near normal thickness after 24 sessions of hyperbaric oxygen therapy. This treatment was effective in resolving scleral necrosis that developed 20 days post-surgery following 3 weeks of topical mitomycin C application.
What This Means for Canadian Patients
For Canadian patients experiencing scleral necrosis after pterygium surgery with mitomycin C, hyperbaric oxygen therapy could be considered as a potential treatment option. This therapy may help revascularize the sclera and restore its thickness, potentially preventing further complications.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, the findings of this study cannot be generalized to a larger patient population.